ARCHIVES

NIH Panel finalizes Consensus Statement; Two Panelists Join In Minority Opinion

This article is from The Cancer Letter archive.

Vol. 23 No. 12 | March 28, 1997

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

May 30, 2008

Phase III BETH Study Combining Avastin And Herceptin Open For Enrollment

June 27, 2008

Who Will Determine Pay Lines For Each Program at NCI? Upton Suggests A Collective Approach

February 17, 1978

ODACSupports Temodal For Treatment of Astrocytoma

January 22, 1999

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

FDA Approves Avastin For Recurrent NSCLC

October 27, 2006